Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
October 10, 2024
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Eivind Valen Egeland, Kotryna Seip, Eleni Skourti, et al.
Science (New York, N.Y.)
|
January 11, 2014
Toddler: an embryonic signal that promotes cell movement via Apelin receptors
Andrea Pauli, Megan L Norris, Eivind Valen, et al.
Diabetologia
|
October 5, 2023
Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes
Pernille Svalastoga, Alba Kaci, Janne Molnes, et al.
Stem Cells and Development
|
May 27, 2014
Generation and characterization of an immortalized human mesenchymal stromal cell line
Magne Skårn, Paul Noordhuis, Meng-Yu Wang, et al.
Molecular Oncology
|
June 21, 2023
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, et al.
Nature Structural & Molecular Biology
|
July 16, 2013
Polyadenylation site-induced decay of upstream transcripts enforces promoter directionality
Evgenia Ntini, Aino I Järvelin, Jette Bornholdt, et al.
Communications Medicine
|
April 30, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential
Pilar Ayuda-Durán, Robert Hanes, Leiv Rønneberg, et al.
Frontiers in Oncology
|
May 20, 2026
CD38<sup>hi</sup>CD19<sup>dim</sup> cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade
Ieva Ailte, Sudhir Kumar Chauhan, Lina Prasmickaite, et al.
Elife
|
December 13, 2021
Rapid genome editing by CRISPR-Cas9-POLD3 fusion
Ganna Reint, Zhuokun Li, Kornel Labun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary Tumors
Amanda Poissonnier, Hope S Rugo, Wesley Horton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
October 10, 2024
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Eivind Valen Egeland, Kotryna Seip, Eleni Skourti, et al.
Science (New York, N.Y.)
|
January 11, 2014
Toddler: an embryonic signal that promotes cell movement via Apelin receptors
Andrea Pauli, Megan L Norris, Eivind Valen, et al.
Diabetologia
|
October 5, 2023
Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes
Pernille Svalastoga, Alba Kaci, Janne Molnes, et al.
Stem Cells and Development
|
May 27, 2014
Generation and characterization of an immortalized human mesenchymal stromal cell line
Magne Skårn, Paul Noordhuis, Meng-Yu Wang, et al.
Molecular Oncology
|
June 21, 2023
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, et al.
Nature Structural & Molecular Biology
|
July 16, 2013
Polyadenylation site-induced decay of upstream transcripts enforces promoter directionality
Evgenia Ntini, Aino I Järvelin, Jette Bornholdt, et al.
Communications Medicine
|
April 30, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential
Pilar Ayuda-Durán, Robert Hanes, Leiv Rønneberg, et al.
Frontiers in Oncology
|
May 20, 2026
CD38<sup>hi</sup>CD19<sup>dim</sup> cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade
Ieva Ailte, Sudhir Kumar Chauhan, Lina Prasmickaite, et al.
Elife
|
December 13, 2021
Rapid genome editing by CRISPR-Cas9-POLD3 fusion
Ganna Reint, Zhuokun Li, Kornel Labun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary Tumors
Amanda Poissonnier, Hope S Rugo, Wesley Horton, et al.
Page
of 8